FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies NEW YORK, NY, UNITED STATES, January 12, 2026 ...
NEW YORK, NY, UNITED STATES, January 12, 2026 /EINPresswire.com/ — Micoy Therapeutics today announced that the NeuroLume™ Test has been granted Breakthrough ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果